NDUFS4 antibody | knockout validation | Santa Cruz sc-100567

This is a knockout-validated antibody summary, based on the publication "Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG2a (kappa light chain)

Company: Santa Cruz

Antibody: NDUFS4

Catalog number: sc-100567

Summary: Mouse monoclonal IgG2a (kappa light chain) against recombinant human NDUFS4. Recommended for detection of NDUFS4 of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA.

Validation Method

Western blot

Sample

Retinas of WT and Ndufs4-KO were dissected and homogenized in 2x cell lysis buffer (Cell Signaling).

Primary incubation

1:1,000 dilution overnight at 4 C.

Secondary incubation

IRDye 680LT goat anti-mouse.

Detection

Odyssey LI-COR was used to scan signals.

Figure

Western-blot results using anti-Ndufs4 antibody in retinas (WT = 3,

KO = 3). Tubulin was used as loading control. Please see Figure 1a in the article [1].

References
  1. Song L, Yu A, Murray K, Cortopassi G. Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model. Brain Res. 2016;: pubmed publisher